Aceragen Inc Asset Turnover Ratio (ACGN), as of first quarter 2023, current and historic results, rankings and more - CSIMarket
CSIMarket
 


Aceragen Inc   (NASDAQ: ACGN)
 

Aceragen Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Aceragen Inc asset turnover ratio, the ability of Aceragen Inc 's assets to generate revenue in the first quarter 2023, increased sequentially to 0.1 in the first quarter (Mar 31 2023), ACGN's balance sheet remain strong.

Within sector Aceragen Inc achieved the highest asset turnover ratio. While asset turnover ranking remained unchanged in the First Quarter 2023 compared to previous quarter at no. .

Asset Turnover Ratio Definition



ACGN Asset Turnover Ratio (Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
Y / Y Asset Change 160.49 % 188.46 % 163.1 % -40.77 % -37.23 %
Y / Y Revenue Change - - - - -
Asset Turnover Ratio (TTM) 0.1 0.07 0 - -
ACGN's Total Ranking # # # # #
Seq. Asset Change -21.95 % -2.44 % 291.86 % -12.7 % -13.57 %
Seq. Revenue Change -48.68 % 9722.45 % - - -



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall Market #

Asset Turnover Ratio Statistics
High Average Low
0 0 0
 







Companies with similar Asset Turnover Ratio for the quarter ending Mar 31 2023, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Mar 31 2023 Assets at quarter ending Mar 31 2023
Invitae Corporation  0.26 $ 509.968  Millions$ 1,990.640  Millions
Telesis Bio Inc   0.25 $ 122.229  Millions$ 491.509  Millions
Alpha Teknova Inc   0.25 $ 39.394  Millions$ 158.937  Millions
Sab Biotherapeutics Inc   0.25 $ 12.682  Millions$ 51.310  Millions
Twist Bioscience Corporation  0.24 $ 227.843  Millions$ 939.086  Millions
Standard Biotools Inc   0.24 $ 96.563  Millions$ 404.500  Millions
Cryoport inc   0.24 $ 247.792  Millions$ 1,041.744  Millions
Beone Medicines Ltd   0.24 $ 1,557.096  Millions$ 6,610.071  Millions
Valion Bio Inc   0.24 $ 1.893  Millions$ 8.048  Millions
Evoke Pharma Inc   0.23 $ 2.901  Millions$ 12.426  Millions
Clever Leaves Holdings Inc   0.23 $ 16.554  Millions$ 71.303  Millions
Quanterix Corporation  0.23 $ 103.194  Millions$ 449.203  Millions
Regen Biopharma Inc   0.23 $ 0.126  Millions$ 0.554  Millions
Aridis Pharmaceuticals Inc   0.23 $ 2.986  Millions$ 13.234  Millions
Dariohealth Corp   0.22 $ 27.595  Millions$ 122.718  Millions
Ionis Pharmaceuticals Inc   0.22 $ 575.972  Millions$ 2,574.300  Millions
Tvardi Therapeutics Inc   0.22 $ 43.242  Millions$ 193.899  Millions
Enanta Pharmaceuticals Inc  0.22 $ 81.176  Millions$ 365.620  Millions
Agenus Inc  0.22 $ 94.985  Millions$ 427.901  Millions
Personalis Inc   0.22 $ 68.680  Millions$ 310.180  Millions
Dyadic International Inc   0.22 $ 3.260  Millions$ 14.742  Millions
Adaptive Biotechnologies Corporation  0.22 $ 184.335  Millions$ 834.730  Millions
Jaguar Health Inc   0.22 $ 11.303  Millions$ 51.388  Millions
Adaptimmune Therapeutics Plc  0.22 $ 72.378  Millions$ 334.367  Millions
Bio rad Laboratories Inc   0.21 $ 2,779.031  Millions$ 12,977.417  Millions
Ligand Pharmaceuticals Incorporated  0.21 $ 194.531  Millions$ 925.159  Millions
Comera Life Sciences Holdings Inc   0.21 $ 0.931  Millions$ 4.449  Millions
Nutriband Inc   0.21 $ 2.079  Millions$ 10.047  Millions
Fortress Biotech Inc   0.21 $ 64.247  Millions$ 311.342  Millions
Cvrx inc   0.20 $ 26.032  Millions$ 127.060  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.